ThinkSono, a London, UK-based medical technology company specializing in ultrasound AI guidance solutions, raised £2.1M in funding.
The round was led by id4 ventures, with participation from Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, CrowdCube, and Cur8 Capital as well as multiple angel investors and clinicians in vascular surgery.
The company intends to use the funds to expand operations and its R&D sector.
Led by CEO Fouad Al Noor, ThinkSono provides Guidance software, which enables non-ultrasound trained healthcare staff to scan patients with suspicion of blood clots (DVT) and send the data for qualified clinician review, thus improving the clinical pathway. For context, DVT is a leading cause of preventable hospital death worldwide. The company, which has partnered with hospitals across Europe, including the UK, Germany and Greece, also announced strategic partnerships with two healthcare companies: NYU Langone Health and Temple Health.
Commenting on the news, Fouad Al Noor said: “This funding will enable us to further advance our mission of revolutionizing medical imaging technology while our partnerships with NYU Langone Health and Temple Health underscore our commitment to delivering innovative solutions that ultimately improve patient outcomes.”
FinSMEs